Clinical trial
Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen…
NCT00134355 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00134355 |
|---|---|
| Title | Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer |
| Official title | Phase II Evaluation of PTK787, an Oral Vascular Endothelial Growth Factor Inhibitor, in Patients With Non-Metastatic Androgen Independent Prostate Cancer |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | PTK787 |
| Enrollment | 5 |
| Start date | Jul 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Aug 24, 2005 |
| Last update posted | Jan 19, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: